No Data
No Data
Oruka Therapeutics to Present at Multiple March Investor Conferences
Stifel Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $49
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Oruka Therapeutics Initiated at Outperform by Wolfe Research
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Wolfe Research Initiates Oruka Therapeutics(ORKA.US) With Buy Rating, Announces Target Price $20